Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Overview of attention for article published in JAMA Oncology, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 3,483)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 4 posts from 3 blogs.

1. Patients receiving autologous tumour lysate-loaded dendritic cell vaccine (DCVax-L) had a 20% relative reduction in death…

Schneider Shorts 2.12.2022 - Stanford president's fake science suddenly in the news, curcumin cheater in Michigan makes lab…

1. In this phase 3 nonrandomized controlled trial, among 331 patients, patients with newly diagnosed glioblastoma (nGBM…

Schneider Shorts 25.11.2022 - how money trumps basic medical ethics for elite London universities, a Belgian failed scientist…